These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 26883305)

  • 21. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychiatric comorbidity associated with synthetic cannabinoid use compared to cannabis.
    Bassir Nia A; Medrano B; Perkel C; Galynker I; Hurd YL
    J Psychopharmacol; 2016 Dec; 30(12):1321-1330. PubMed ID: 27462088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is the party over? Cannabis and juvenile psychiatric disorder: the past 10 years.
    Rey JM; Martin A; Krabman P
    J Am Acad Child Adolesc Psychiatry; 2004 Oct; 43(10):1194-205. PubMed ID: 15381886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiometabolic risk factors in people with psychotic disorders: the second Australian national survey of psychosis.
    Galletly CA; Foley DL; Waterreus A; Watts GF; Castle DJ; McGrath JJ; Mackinnon A; Morgan VA
    Aust N Z J Psychiatry; 2012 Aug; 46(8):753-61. PubMed ID: 22761397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subclinical depressive symptoms and continued cannabis use: predictors of negative outcomes in first episode psychosis.
    González-Ortega I; Alberich S; Echeburúa E; Aizpuru F; Millán E; Vieta E; Matute C; González-Pinto A
    PLoS One; 2015; 10(4):e0123707. PubMed ID: 25875862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cannabis and psychosis].
    Nordentoft M
    Ugeskr Laeger; 2006 Nov; 168(45):3896-8. PubMed ID: 17118250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abrupt Quitting of Long-term Heavy Recreational Cannabis Use is Not Followed by Significant Changes in Blood Pressure and Heart Rate.
    Bonnet U
    Pharmacopsychiatry; 2016 Jan; 49(1):23-5. PubMed ID: 26761126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cannabis use in children and adolescents with first episode psychosis: influence on psychopathology and short-term outcome (CAFEPS study).
    Baeza I; Graell M; Moreno D; Castro-Fornieles J; Parellada M; González-Pinto A; Payá B; Soutullo C; de la Serna E; Arango C
    Schizophr Res; 2009 Sep; 113(2-3):129-37. PubMed ID: 19427172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistent Low Rates of Treatment of Metabolic Risk Factors in People With Psychotic Disorders: A PHAMOUS Study.
    Bruins J; Pijnenborg GHM; van den Heuvel ER; Visser E; Corpeleijn E; Bartels-Velthuis AA; Bruggeman R; Jörg F
    J Clin Psychiatry; 2017; 78(8):1117-1125. PubMed ID: 28406264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of the Cannabis Expectancy Questionnaire (CEQ) in adult cannabis users in treatment.
    Connor JP; Gullo MJ; Feeney GF; Young RM
    Drug Alcohol Depend; 2011 Jun; 115(3):167-74. PubMed ID: 21163593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are cannabis-using and non-using patients different groups? Towards understanding the neurobiology of cannabis use in psychotic disorders.
    Sami MB; Bhattacharyya S
    J Psychopharmacol; 2018 Aug; 32(8):825-849. PubMed ID: 29591635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabis use and cannabis use disorders among individuals with mental illness.
    Lev-Ran S; Le Foll B; McKenzie K; George TP; Rehm J
    Compr Psychiatry; 2013 Aug; 54(6):589-98. PubMed ID: 23375264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of herbal cannabis use with negative psychosocial parameters in patients with fibromyalgia.
    Ste-Marie PA; Fitzcharles MA; Gamsa A; Ware MA; Shir Y
    Arthritis Care Res (Hoboken); 2012 Aug; 64(8):1202-8. PubMed ID: 22730275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased cardiovascular risk in patients with severe mental illness.
    Gladigau EL; Fazio TN; Hannam JP; Dawson LM; Jones SG
    Intern Med J; 2014 Jan; 44(1):65-9. PubMed ID: 24383746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in demographic and clinical characteristics between cannabis users and non-drug users: A retrospective study of patients at first hospitalization due to psychotic symptoms.
    Balan Moshe L; Weizman A; Ben Dor DH; Konas S; Fischel Z; Aizenberg D; Gothelf D; Valevski A
    Psychiatry Res; 2018 Oct; 268():454-459. PubMed ID: 30130713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sex differences in the cardiometabolic health of cannabis users with a psychotic illness.
    Waterreus A; Di Prinzio P; Martin-Iverson MT; Morgan VA
    Drug Alcohol Depend; 2019 Jan; 194():447-452. PubMed ID: 30502546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabis and mental health.
    Fernández-Artamendi S; Fernández-Hermida JR; Secades-Villa R; García-Portilla P
    Actas Esp Psiquiatr; 2011; 39(3):180-90. PubMed ID: 21560079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mental health symptoms and their relationship to cannabis use in adolescents attending residential treatment.
    Albertella L; Norberg MM
    J Psychoactive Drugs; 2012; 44(5):381-9. PubMed ID: 23457889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gender differences in health-related quality of life among cannabis users: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Lev-Ran S; Imtiaz S; Taylor BJ; Shield KD; Rehm J; Le Foll B
    Drug Alcohol Depend; 2012 Jun; 123(1-3):190-200. PubMed ID: 22143039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.